Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial von Zhang, Shihong, Kohli, Karan, Black, R Graeme, Yao, Lu, Spadinger, Sydney M, He, Qianchuan, Pillarisetty, Venu G, Cranmer, Lee D, Van Tine, Brian A, Yee, Cassian, Pierce, Robert H, Riddell, Stanley R, Jones, Robin L, Pollack, Seth M

Volltext

Histiocyte predominant myocarditis resulting from the addition of interferon gamma to cyclophosphamide-based lymphodepletion for adoptive cellular therapy von Schroeder, Brett A, Black, Ralph Graeme, Spadinger, Sydney, Zhang, Shihong, Kohli, Karan, Cao, Jianhong, Mantilla, Jose G, Conrad, Ernest U, Riddell, Stanley R, Jones, Robin L, Yee, Cassian, Pollack, Seth M

Volltext

Abstract 2754: LYL797, a ROR1 CAR T-cell therapy with genetic and epigenetic reprogramming for solid tumors von Park, Spencer, Simianer, Courtney, Spadinger, Sydney, Wang, Xiao, Sundar, Purnima, Potluri, Shobha, Lynn, Rachel, Boldajipour, Bijan, Wang, Grace, Sharma, Neeraj, Hiraragi, Hajime, Krishnamoorthy, Veena, Vodnala, Suman Kumar, Ong, E-Ching, Wu, Chang-Chih, Wohlfahrt, Martin, Ryu, Byoung, Song, Lisa, Weitzner, Brian D., Moffett, Howell, Lajoie, Marc, Boyken, Scott, Shabaneh, Tamer, Srivastava, Shivani, Albertson, Tina, Sather, Blythe

Volltext